Similar articles

• Biology of the multidrug resistance-associated protein, MRP.

  Loe DW, Deeley RG, Cole SP. Loe DW, et al. Eur J Cancer. 1996 Jun;32A(6):945-57. doi: 10.1016/0959-8049(96)00046-9. Eur J Cancer. 1996. PMID: 8763335 Review. No abstract available.
• Role of gene amplification in drug resistance.

  Schoenlein PV. Schoenlein PV. Cancer Treat Res. 1994;73:167-200. doi: 10.1007/978-1-4615-2632-2_9. Cancer Treat Res. 1994. PMID: 7710905 Review. No abstract available.
• The role of protein kinase C in multidrug resistance.

  O'Brian CA, Ward NE, Gravitt KR, Fan D. O'Brian CA, et al. Cancer Treat Res. 1994;73:41-55. doi: 10.1007/978-1-4615-2632-2_3. Cancer Treat Res. 1994. PMID: 7710909 Review. No abstract available.
• Clinical reversal of multidrug resistance.

  Sikic BI, Fisher GA, Lum BL, Brophy NA, Yahanda AM, Adler KM, Halsey J. Sikic BI, et al. Cancer Treat Res. 1994;73:149-65. doi: 10.1007/978-1-4615-2632-2_8. Cancer Treat Res. 1994. PMID: 7710904 Review. No abstract available.
• P-glycoprotein--a mediator of multidrug resistance in tumour cells.

  Germann UA. Germann UA. Eur J Cancer. 1996 Jun;32A(6):927-44. doi: 10.1016/0959-8049(96)00057-3. Eur J Cancer. 1996. PMID: 8763334 Review. No abstract available.